retatrutide peptide vs tirzepatide #tirzepatide at a glance… #onthepen Retatrutide vs Tirzepatide vs Semaglutide

it should only be used within the context of authorised clinical trials

The net result is a compound that addresses energy balance from both sides simultaneously: reducing intake via appetite suppression (GLP-1R + GIPR) and increasing expenditure via thermogenesis and hepatic oxidation (GCGR)

GLP-1s are approved for weight loss in adults who have a body mass index of 30 or higher, and those who are overweight with a body mass index of 27 or higher with at least one weight-related health condition such as high blood pressure, high cholesterol and type 2 diabetes

Semaglutide is administered once per week via subcutaneous injection, typically into the abdomen, thigh or upper arm